Conference Coverage
Latest News
Rethinking Management of Skin Cancer in Older Patients
The dermatologist's risk assessment -- both staging and stratifying risk as it relates to specific outcomes such as recurrence, metastases, or...
Conference Coverage
DLBCL: Glofitamab Plus Chemo Boosts Survival
The bispecific antibody glofitamab, combined with chemotherapy, significantly improves overall survival in second-line treatment of DLBCL.
Conference Coverage
Lung Cancer Expert at ASCO: From Fatal to ‘Chronic Disease’
Tony Shu-Kam Mok, MD, discusses latest KRAS G12C findings and more.
Conference Coverage
APL: Should Chemo-Free Regimen Become New Standard?
Fresh data indicates that the benefits of a chemo-free regimen also extend to the treatment of high-risk acute promyelocytic leukemia.
Conference Coverage
Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BC
An expanded analysis of the INAVO120 trial looks at time from randomization to end of next-line treatment, time to first chemotherapy, and patient...
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...
Latest News
Surviving to Thriving: Enhancing Quality of Life in Breast Cancer
Up to 90% of early breast cancer survivors experience long-term effects from treatment, which often include fatigue, loss of mobility, chronic...
Conference Coverage
Ovarian Cancer Risk Doubled by Estrogen-Only HRT
Long-term follow up in women with hysterectomy included in the WHI reveals significantly more cases of ovarian cancer.
Latest News
Study Highlights Melanoma Survival Disparities in Rural vs Urban Settings
To characterize the rural population diagnosed with melanoma and assess associated disparities in the United States, researchers used data from...
Latest News
Features of Merkel Cell in Hispanic Patients Explored
The incidence of Merkel cell carcinoma is increasing among all racial groups, especially in the Hispanic population.
Conference Coverage
Chemo May Benefit Some Older Patients With Metastatic Pancreatic Cancer
Researchers examine real-world outcomes of older adults with untreated metastatic pancreatic cancer.